With the advent of the corono virus and drastically disrupted supply chains, the need to change business process and adopting a different mindset is quintessential. Especially in the pharmaceutical industry where catering the needs of patients at the right time is a noble responsibility.
“Respond, Recover and Thrive” is Kirti Attar’s approach to deal with such unprecedented times. Her company Johnson &Johnson has created a crisis management team for all verticals and segments of supply chain, to analyze and mitigate the impact of covid19.
On being asked, “How have you coped up with the domestic and export requirements and maintained an equilibrium between the two? “Vikram Srivastava, Ipca Laboratories refers this as a Black Swan event. Allocating all resources to manufacture HCL Andchloroquine which helped in the Covid war has been the priority of the company since day one. Along with maximizing capacity, replenishing supply chain, building inventory and day-wise planning helped them procure effectively.
Mr. Gaurav Bhatia threw light on how Cipla has been managing their supply of raw materials by aligning with key APIs and suppliers along with government support.
Mr. Chandan Shirbhayye provided with an elaborate insight on the feasible movement of raw materials with their innovative approach. GVK Bio leased trucks, did route mapping and played as an aggregator in the market. They began to witness their competitors as peers and consolidated mutual requirements as in the case of Carter planes. Taking care of shop floor employees during crisis is one important measure he highlighted to quickly bounce back.
MasudShaikh, Alembic Pharmaceuticals highlighted on the “(WFH)Work from Home” aspect. Formatting responsibility and empowering CFAs alongwith a flexible hierarchy had worked for this firm. He also stressed on sourcing local suppliers and derisking.
Amitaggarwal, Dr. Lal Path Labs emphasized on the hardships of reduction in manpower, clarity around local authorities’ behavior and lack of rawmaterials which are samples from patients. They managed the situation by decentralizing decision-making and used Indian Railways for transportation.
Manish Gahlaut, Novartis India explained the northward shift in cost and the role of external and mutual collaboration to derive efficiency.
Nikunj Desai, ACG Worldwide, mentioned about the challenges to build repo due to travel restrain which can be surmounted by powerful teleconferencing tools.
Sudipto Basu, Boehringer Ingleheim laid stress on a strong (BCP) Business Continuity Plan and the importance of understanding demand by devising a weekly SNOP (Sales&Operations Planning).
Click on the link for more info https://thealdenglobal.com/tech-innovation-inflection-web-conference-awards/